Table 1—Approved NDAs for Which Required Reports Have Not Been Submitted
Application No. Drug Holder NDA 004652 ORETON (testosterone) Pellets for Subcutaneous Implantations, 75 milligrams (mg) Progynon Associates, 9300 Wilshire Blvd., Beverly Hills, CA 90212. NDA 013268 WINSTEROID (stanozolol) Tablets, 2 mg Sterling Winthrop Inc., 90 Park Ave., New York, NY 10016. NDA 017455 Copper T Model TCu 200B (copper) Intrauterine Device Duramed Research, Inc., 425 Privet Rd., Horsham, PA 19044. NDA 205003 PRESTALIA (amlodipine besylate/perindopril arginine) Tablets, equivalent to (EQ) 2.5 mg base/3.5mg, EQ 5 mg base/7 mg, and EQ 10 mg base/14 mg Adhera Therapeutics, Inc., 224 Holding Ave., Wake Forest, NC 27588.
Document Information
- Published:
- 09/23/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2024-21680
- Dates:
- Approval is withdrawn as of September 23, 2024.
- Pages:
- 77515-77515 (1 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-2219
- PDF File:
- 2024-21680.pdf